Healthcare & Life Sciences
Gemin X
Canada
acquiredacquired
acquired
Stage
About
Gemin X was a Canadian biotechnology company focused on developing oncology therapeutics. It was acquired by Cephalon in 2003 for $225 million.
Explore Gemin X's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.